Hospital-based norovirus surveillance in children <5 years of age from 2017 to 2019 in India

J Med Virol. 2024 Jan;96(1):e29384. doi: 10.1002/jmv.29384.

Abstract

After the introduction of the rotavirus vaccine into the Universal Immunization Program in India in 2016, relatively few studies have assessed the prevalence and epidemiological patterns of acute gastroenteritis (AGE) among hospitalized children ≤5 years of age. We used a uniform protocol to recruit children with AGE as well as standardized testing and typing protocols. Stool specimens from children with AGE younger than 5 years of age admitted to six hospitals in three cities in India were collected from January 2017 through December 2019. Norovirus was detected by real-time reverse transcription-polymerase chain reaction (RT-qPCR) followed by typing positive specimens by conventional RT-PCR and Sanger sequencing. Norovirus was detected in 322 (14.8%) of 2182 specimens with the highest rate in 2018 (17.6%, 146/829), followed by 2019 (14.4%, 122/849) and 2017 (10.7%, 54/504). Rotavirus vaccine status was known for 91.6% of the children of which 70.4% were vaccinated and 29.6% not. Norovirus positivity in rotavirus-vaccinated children was 16.3% and 12% in unvaccinated children. GII.4 Sydney[P16] (39.3%), GII.4 Sydney[P31] (18.7%), GII.2[P16] (10%), GI.3[P13] (6.8%), GII.3[P16] (5.9%), and GII.13[P16] (5%) accounted for 85.8% (188/219) of the typed strains. Our data highlight the importance of norovirus in Indian children hospitalized with AGE.

Keywords: India; acute gastroenteritis; hospitalized children; norovirus.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Caliciviridae Infections* / epidemiology
  • Child
  • Child, Preschool
  • Feces
  • Genotype
  • Hospitals
  • Humans
  • India / epidemiology
  • Infant
  • Norovirus* / genetics
  • Phylogeny
  • Rotavirus Vaccines*
  • Rotavirus*

Substances

  • Rotavirus Vaccines